Annual D&A
$1.28 M
+$497.00 K+63.64%
December 31, 2023
Summary
- As of February 8, 2025, LVTX annual depreciation & amortization is $1.28 million, with the most recent change of +$497.00 thousand (+63.64%) on December 31, 2023.
- During the last 3 years, LVTX annual D&A has risen by +$814.00 thousand (+175.43%).
- LVTX annual D&A is now at all-time high.
Performance
LVTX Depreciation And Amortization Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Related metrics
Quarterly D&A
$212.00 K
-$16.00 K-7.02%
September 30, 2024
Summary
- As of February 8, 2025, LVTX quarterly depreciation & amortization is $212.00 thousand, with the most recent change of -$16.00 thousand (-7.02%) on September 30, 2024.
- Over the past year, LVTX quarterly D&A has dropped by -$106.00 thousand (-33.33%).
- LVTX quarterly D&A is now -39.77% below its all-time high of $352.00 thousand, reached on December 31, 2023.
Performance
LVTX Quarterly D&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Related metrics
TTM D&A
$1.04 M
-$106.00 K-9.26%
September 30, 2024
Summary
- As of February 8, 2025, LVTX TTM depreciation & amortization is $1.04 million, with the most recent change of -$106.00 thousand (-9.26%) on September 30, 2024.
- Over the past year, LVTX TTM D&A has dropped by -$158.00 thousand (-13.20%).
- LVTX TTM D&A is now -18.70% below its all-time high of $1.28 million, reached on December 31, 2023.
Performance
LVTX TTM D&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Related metrics
LVTX Depreciation And Amortization Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +63.6% | -33.3% | -13.2% |
| 3 y3 years | +175.4% | -33.3% | -13.2% |
| 5 y5 years | +393.4% | -33.3% | -13.2% |
LVTX Depreciation And Amortization Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +129.0% | -39.8% | +47.2% | -18.7% | +86.2% |
| 5 y | 5-year | at high | +393.4% | -39.8% | +434.0% | -18.7% | +2517.1% |
| alltime | all time | at high | +393.4% | -39.8% | +434.0% | -18.7% | +2517.1% |
LAVA Therapeutics NV Depreciation And Amortization History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | $212.00 K(-7.0%) | $1.04 M(-9.3%) |
| Jun 2024 | - | $228.00 K(-7.7%) | $1.15 M(-5.5%) |
| Mar 2024 | - | $247.00 K(-29.8%) | $1.21 M(-5.2%) |
| Dec 2023 | $1.28 M(+63.6%) | $352.00 K(+10.7%) | $1.28 M(+6.8%) |
| Sep 2023 | - | $318.00 K(+7.8%) | $1.20 M(+14.3%) |
| Jun 2023 | - | $295.00 K(-5.8%) | $1.05 M(+13.1%) |
| Mar 2023 | - | $313.00 K(+15.5%) | $926.00 K(+18.6%) |
| Dec 2022 | $781.00 K | $271.00 K(+61.3%) | $781.00 K(+19.4%) |
| Sep 2022 | - | $168.00 K(-3.4%) | $654.00 K(+2.7%) |
| Jun 2022 | - | $174.00 K(+3.6%) | $637.00 K(+6.7%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2022 | - | $168.00 K(+16.7%) | $597.00 K(+7.0%) |
| Dec 2021 | $558.00 K(+20.3%) | $144.00 K(-4.6%) | $558.00 K(-22.4%) |
| Sep 2021 | - | $151.00 K(+12.7%) | $719.50 K(+13.1%) |
| Jun 2021 | - | $134.00 K(+3.9%) | $635.90 K(+14.9%) |
| Mar 2021 | - | $129.00 K(-57.8%) | $553.30 K(+19.2%) |
| Dec 2020 | $464.00 K(+79.2%) | $305.50 K(+353.3%) | $464.00 K(+192.7%) |
| Sep 2020 | - | $67.40 K(+31.1%) | $158.50 K(+74.0%) |
| Jun 2020 | - | $51.40 K(+29.5%) | $91.10 K(+129.5%) |
| Mar 2020 | - | $39.70 K | $39.70 K |
| Dec 2019 | $259.00 K | - | - |
FAQ
- What is LAVA Therapeutics NV annual depreciation & amortization?
- What is the all time high annual D&A for LAVA Therapeutics NV?
- What is LAVA Therapeutics NV annual D&A year-on-year change?
- What is LAVA Therapeutics NV quarterly depreciation & amortization?
- What is the all time high quarterly D&A for LAVA Therapeutics NV?
- What is LAVA Therapeutics NV quarterly D&A year-on-year change?
- What is LAVA Therapeutics NV TTM depreciation & amortization?
- What is the all time high TTM D&A for LAVA Therapeutics NV?
- What is LAVA Therapeutics NV TTM D&A year-on-year change?
What is LAVA Therapeutics NV annual depreciation & amortization?
The current annual D&A of LVTX is $1.28 M
What is the all time high annual D&A for LAVA Therapeutics NV?
LAVA Therapeutics NV all-time high annual depreciation & amortization is $1.28 M
What is LAVA Therapeutics NV annual D&A year-on-year change?
Over the past year, LVTX annual depreciation & amortization has changed by +$497.00 K (+63.64%)
What is LAVA Therapeutics NV quarterly depreciation & amortization?
The current quarterly D&A of LVTX is $212.00 K
What is the all time high quarterly D&A for LAVA Therapeutics NV?
LAVA Therapeutics NV all-time high quarterly depreciation & amortization is $352.00 K
What is LAVA Therapeutics NV quarterly D&A year-on-year change?
Over the past year, LVTX quarterly depreciation & amortization has changed by -$106.00 K (-33.33%)
What is LAVA Therapeutics NV TTM depreciation & amortization?
The current TTM D&A of LVTX is $1.04 M
What is the all time high TTM D&A for LAVA Therapeutics NV?
LAVA Therapeutics NV all-time high TTM depreciation & amortization is $1.28 M
What is LAVA Therapeutics NV TTM D&A year-on-year change?
Over the past year, LVTX TTM depreciation & amortization has changed by -$158.00 K (-13.20%)